Neuropeptide α-Melanocyte-Stimulating Hormone Promotes Neurological Recovery and Repairs Cerebral Ischemia/Reperfusion Injury in Type 1 Diabetes

[1]  Xiaoying Wang,et al.  Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy , 2020, Translational Stroke Research.

[2]  Junying Yuan,et al.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke , 2020, Proceedings of the National Academy of Sciences.

[3]  FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder , 2019, Case Medical Research.

[4]  FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women , 2019, Case Medical Research.

[5]  A. Demchuk,et al.  Rapid Alteplase Administration Improves Functional Outcomes in Patients With Stroke due to Large Vessel Occlusions: Meta-Analysis of the Noninterventional Arm From the HERMES Collaboration , 2019, Stroke.

[6]  Vincent Thijs,et al.  Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review , 2018, Journal of diabetes investigation.

[7]  R. Leak,et al.  A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  A. Rosengren,et al.  Glycaemic control and excess risk of ischaemic and haemorrhagic stroke in patients with type 1 diabetes: a cohort study of 33 453 patients , 2017, Journal of internal medicine.

[9]  M. Owolabi,et al.  Stroke: a global response is needed , 2016, Bulletin of the World Health Organization.

[10]  W. Feng,et al.  Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes☆,☆☆ , 2016, The American journal of the medical sciences.

[11]  S. Ding,et al.  Reactive astrocytes and therapeutic potential in focal ischemic stroke , 2016, Neurobiology of Disease.

[12]  Shao-wei Jiang,et al.  Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke , 2015, PloS one.

[13]  Mulugeta Gebregziabher,et al.  The burden of stroke in Africa: a glance at the present and a glimpse into the future , 2015, Cardiovascular journal of Africa.

[14]  V. Feigin,et al.  Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.

[15]  M. Perretti,et al.  Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides , 2013, International journal of inflammation.

[16]  M. Fisher,et al.  Advanced imaging to extend the therapeutic time window of acute ischemic stroke , 2013, Annals of neurology.

[17]  J. Hewitt,et al.  Diabetes and Stroke Prevention: A Review , 2012, Stroke research and treatment.

[18]  Pierre J. Magistretti,et al.  New Evidence of Neuroprotection by Lactate after Transient Focal Cerebral Ischaemia: Extended Benefit after Intracerebroventricular Injection and Efficacy of Intravenous Administration , 2012, Cerebrovascular Diseases.

[19]  M. Eriksson,et al.  The Disparity in Long-Term Survival after a First Stroke in Patients with and without Diabetes Persists: The Northern Sweden MONICA Study , 2012, Cerebrovascular Diseases.

[20]  K. Lambertsen,et al.  Inflammatory Cytokines in Experimental and Human Stroke , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  A. Ergul,et al.  Cerebrovascular complications of diabetes: focus on stroke. , 2012, Endocrine, metabolic & immune disorders drug targets.

[22]  R. Chang,et al.  Lycium barbarum Extracts Protect the Brain from Blood-Brain Barrier Disruption and Cerebral Edema in Experimental Stroke , 2012, PloS one.

[23]  D. Wong,et al.  Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke , 2012, Neurobiology of Disease.

[24]  K. Cain,et al.  Plasma &agr;-Melanocyte Stimulating Hormone Predicts Outcome in Ischemic Stroke , 2011, Stroke.

[25]  Ken Butcher,et al.  Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target , 2011, The Lancet Neurology.

[26]  R. Flower,et al.  Targeting the melanocortin receptor system for anti-stroke therapy. , 2011, Trends in pharmacological sciences.

[27]  K. Becker,et al.  α-MSH: A Potential Neuroprotective and Immunomodulatory Agent for the Treatment of Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Eric E. Smith,et al.  Quality of Care and Outcomes in Patients With Diabetes Hospitalized With Ischemic Stroke: Findings From Get With the Guidelines–Stroke , 2010, Stroke.

[29]  Rolf Gruetter,et al.  Neuroprotective Role of Lactate after Cerebral Ischemia , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[31]  S. Nielsen,et al.  Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone , 2008, Neuropeptides.

[32]  T. Luger,et al.  -Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases , 2008 .

[33]  A. Bitto,et al.  Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. , 2007, European journal of pharmacology.

[34]  T. Dawson,et al.  Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death , 2006, Proceedings of the National Academy of Sciences.

[35]  K. Sundquist,et al.  Type 1 diabetes as a risk factor for stroke in men and women aged 15–49: a nationwide study from Sweden , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[36]  N. Plesnila,et al.  Apoptosis-Inducing Factor Triggered by Poly(ADP-Ribose) Polymerase and Bid Mediates Neuronal Cell Death after Oxygen-Glucose Deprivation and Focal Cerebral Ischemia , 2005, The Journal of Neuroscience.

[37]  T. Gardner,et al.  The Ins2Akita mouse as a model of early retinal complications in diabetes. , 2005, Investigative ophthalmology & visual science.

[38]  B. Winblad,et al.  Alpha-MSH decreases core and brain temperature during global cerebral ischemia in rats. , 2005, Neuroreport.

[39]  T. Dawson,et al.  Apoptosis-Inducing Factor Substitutes for Caspase Executioners in NMDA-Triggered Excitotoxic Neuronal Death , 2004, The Journal of Neuroscience.

[40]  Y. Çelik,et al.  Factors affecting haemorrhagic transformation in middle cerebral artery infarctions , 2004, Journal of Clinical Neuroscience.

[41]  R. Roine,et al.  Hyperglycemia in Acute Stroke , 2004, Stroke.

[42]  J. Kupiec-Weglinski,et al.  Heme oxygenase system in ischemia and reperfusion injury. , 2003, Annals of transplantation.

[43]  P. Kovacs,et al.  The administration of alpha-melanocyte-stimulating hormone protects the ischemic/reperfused myocardium. , 2003, European journal of pharmacology.

[44]  E. Chang,et al.  Heme Oxygenase-2 Protects against Lipid Peroxidation-Mediated Cell Loss and Impaired Motor Recovery after Traumatic Brain Injury , 2003, The Journal of Neuroscience.

[45]  K. Fukunaga,et al.  Decreased Akt Activity is Associated with Activation of Forkhead Transcription Factor after Transient Forebrain Ischemia in Gerbil Hippocampus , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[47]  S. Mori,et al.  Poly(ADP-Ribose) Polymerase Impairs Early and Long-Term Experimental Stroke Recovery , 2002, Stroke.

[48]  M. Fillenz,et al.  Lactate reduces glutamate‐induced neurotoxicity in rat cortex , 2001, Journal of neuroscience research.

[49]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[50]  K. Fukunaga,et al.  Activation of Akt/Protein Kinase B Contributes to Induction of Ischemic Tolerance in the CA1 Subfield of Gerbil Hippocampus , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  J. Roberts,et al.  Decreased nuclear factor-κB DNA binding activity following permanent focal cerebral ischaemia in the rat , 2000, Neuroscience Letters.

[52]  A. Dávalos,et al.  Nitric oxide-related brain damage in acute ischemic stroke. , 2000, Stroke.

[53]  P. Colville-Nash,et al.  COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease , 2000, The Lancet.

[54]  M. Ross,et al.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia , 1999, Acta Neuropathologica.

[55]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[56]  Masato Yoshioka,et al.  A Novel Locus, Mody4, Distal to D7Mit189 on Chromosome 7 Determines Early-Onset NIDDM in Nonobese C57BL/6 (Akita) Mutant Mice , 1997, Diabetes.

[57]  I. Housini,et al.  Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. , 1997, The Journal of clinical investigation.

[58]  W. Banks,et al.  Permeability of the blood-brain barrier to melanocortins , 1995, Peptides.

[59]  W. X,et al.  Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies. , 2016, Biochemistry & pharmacology : open access.

[60]  M. Hahne,et al.  Cell Death , 2010, Cell Death and Differentiation.

[61]  B. Winblad,et al.  alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. , 2006, Neuropeptides.

[62]  Guo-Yuan Yang,et al.  Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice. , 2003, Journal of neuroscience research.

[63]  J. M. Lipton,et al.  Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. , 2003, Journal of neurotrauma.

[64]  J. B. Tatro,et al.  Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice. , 2002, Neuroscience letters.

[65]  F. Moore,et al.  Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[66]  M. Mattson,et al.  NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.

[67]  A. Martin-Villalba,et al.  NF-kappaB is activated and promotes cell death in focal cerebral ischemia. , 1999, Nature medicine.

[68]  N. Kawai,et al.  Hyperglycemia and the vascular effects of cerebral ischemia. , 1997, Acta neurochirurgica. Supplement.

[69]  J. M. Lipton,et al.  The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. , 1997, Neurosurgery.